Saturn V Capital Management LP Diversified Active

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value: $239M (100.0% shares, 0.0% debt)

Holdings (20)

CRNX CRINETICS PHARMACEUTICALS IN 14.0%

Value $33.5M Shares 1,126,579 Est. Cost $18.62 Unrealized +10.7%

KALV KALVISTA PHARMACEUTICALS INC 7.3%

Value $17.43M Shares 1,810,246 Est. Cost $7.51 Unrealized +36.0%

COGT COGENT BIOSCIENCES INC 7.2%

Value $17.31M Shares 1,775,415 Est. Cost $11.61 Unrealized +2.1%

— CYMABAY THERAPEUTICS INC 7.0%

Value $16.77M Shares 1,124,459 Est. Cost $3.60 Unrealized —

BIIB BIOGEN INC 7.0%

Value $16.62M Shares 64,676 Est. Cost $275.18 Unrealized -2.8%

AMLX AMYLYX PHARMACEUTICALS INC 6.8%

Value $16.23M Shares 886,143 Est. Cost $21.15 Unrealized 0.0%

CYTK CYTOKINETICS INC 6.1%

Value $14.59M Shares 495,168 Est. Cost $39.36 Unrealized -15.4%

SRPT SAREPTA THERAPEUTICS INC 6.0%

Value $14.35M Shares 118,401 Est. Cost $120.22 Unrealized -6.0%

— HORIZON THERAPEUTICS PUB L 5.4%

Value $12.85M Shares 111,045 Est. Cost $92.95 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 4.9%

Value $11.73M Shares 807,969 Est. Cost $19.32 Unrealized -2.1%

— ITEOS THERAPEUTICS INC 4.6%

Value $10.89M Shares 994,756 Est. Cost $14.98 Unrealized —

ASND ASCENDIS PHARMA A/S 4.4%

Value $10.53M Shares 112,473 Est. Cost $108.42 Unrealized —

ANAB ANAPTYSBIO INC 4.3%

Value $10.36M Shares 577,101 Est. Cost $19.08 Unrealized 0.0%

BMRN BIOMARIN PHARMACEUTICAL INC 4.1%

Value $9.705M Shares 109,685 Est. Cost $93.31 Unrealized -4.6%

— ASTRIA THERAPEUTICS INC 3.8%

Value $9.094M Shares 1,219,093 Est. Cost $7.99 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 2.9%

Value $6.956M Shares 982,458 Est. Cost $10.37 Unrealized -30.7%

ARGX ARGENX SE 2.1%

Value $4.953M Shares 10,074 Est. Cost $450.35 Unrealized —

— MORPHIC HLDG INC 1.3%

Value $3.133M Shares 136,743 Est. Cost $27.33 Unrealized —

— JASPER THERAPEUTICS INC 0.4%

Value $971K Shares 1,387,015 Est. Cost $0.70 Unrealized —

— MERUS N V 0.4%

Value $945K Shares 40,066 Est. Cost $23.58 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CRNX	CRINETICS PHARMACEUTICALS IN	1,126,579	$33.5M	14.0%	$18.62	+10.7%	COM	22663K107
KALV	KALVISTA PHARMACEUTICALS INC	1,810,246	$17.43M	7.3%	$7.51	+36.0%	COM	483497103
COGT	COGENT BIOSCIENCES INC	1,775,415	$17.31M	7.2%	$11.61	+2.1%	COM	19240Q201
—	CYMABAY THERAPEUTICS INC	1,124,459	$16.77M	7.0%	$3.60	—	COM	23257D103
BIIB	BIOGEN INC	64,676	$16.62M	7.0%	$275.18	-2.8%	COM	09062X103
AMLX	AMYLYX PHARMACEUTICALS INC	886,143	$16.23M	6.8%	$21.15	0.0%	COM	03237H101
CYTK	CYTOKINETICS INC	495,168	$14.59M	6.1%	$39.36	-15.4%	COM NEW	23282W605
SRPT	SAREPTA THERAPEUTICS INC	118,401	$14.35M	6.0%	$120.22	-6.0%	COM	803607100
—	HORIZON THERAPEUTICS PUB L	111,045	$12.85M	5.4%	$92.95	—	SHS	G46188101
SNDX	SYNDAX PHARMACEUTICALS INC	807,969	$11.73M	4.9%	$19.32	-2.1%	COM	87164F105
—	ITEOS THERAPEUTICS INC	994,756	$10.89M	4.6%	$14.98	—	COM	46565G104
ASND	ASCENDIS PHARMA A/S	112,473	$10.53M	4.4%	$108.42	—	SPONSORED ADR	04351P101
ANAB	ANAPTYSBIO INC	577,101	$10.36M	4.3%	$19.08	0.0%	COM	032724106
BMRN	BIOMARIN PHARMACEUTICAL INC	109,685	$9.705M	4.1%	$93.31	-4.6%	COM	09061G101
—	ASTRIA THERAPEUTICS INC	1,219,093	$9.094M	3.8%	$7.99	—	COM	04635X102
BCRX	BIOCRYST PHARMACEUTICALS INC	982,458	$6.956M	2.9%	$10.37	-30.7%	COM	09058V103
ARGX	ARGENX SE	10,074	$4.953M	2.1%	$450.35	—	SPONSORED ADR	04016X101
—	MORPHIC HLDG INC	136,743	$3.133M	1.3%	$27.33	—	COM	61775R105
—	JASPER THERAPEUTICS INC	1,387,015	$971K	0.4%	$0.70	—	COM	471871103
—	MERUS N V	40,066	$945K	0.4%	$23.58	—	COM	N5749R100